LANSING, Mich. — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has launched a new food extraction method that expands the capabilities of select Reveal® 3-D food allergen tests to include the direct testing of food products. NEOGEN’s new Reveal 3-D Food Buffer allows for the rapid screening of food and ingredient samples as low as […]
NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, […]
Washington University School of Medicine in St. Louis professor recognized for research in cellular immunotherapy SANTA CLARA, Calif.– Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation Oncology at the Washington University School of Medicine in St. Louis, […]
ERS Genomics announces agreement with FASMAC to commercialize CRISPR/Cas9 research reagents in Japan
Food analysis and biotechnology company licenses gene editing technology Dublin, Ireland, and Kanagawa, Japan: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with FASMAC Co., Ltd (“FASMAC”) of Japan. Under the terms of the […]
ST. LOUIS & NATICK, Mass. — PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. Under the agreement, PierianDx will integrate the Pillar Biosciences […]
Funding will support development of novel proteomic devices based on quantum sensing BOULDER, Colo., October 13, 2020 — SomaLogic, Inc. announced today that a collaborative project between SomaLogic scientists and academic researchers at the University of Chicago, University of California, Los Angeles, University of California, Santa Barbara, and University of Washington, Seattle has received a […]
Latest Addition to the Mastermind Genomic Search Engine will Further Accelerate Clinical Workflow Genomenon® announced today that the latest release of the Mastermind® Genomic Search Engine includes Copy Number Variation (CNV) search. Since 5-30% of genetic disease is caused by deletion or duplication of genomic material, this new functionality will further accelerate diagnosis and interpretation of results for patients […]
Oxford, UK: The funding comes from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen. The funds will support the rapid acceleration of Oxford Nanopore’s commercial and manufacturing operations as well as ongoing innovation in the field of nanopore technology. “We are delighted to welcome our new shareholders,” said Dr Gordon […]
IP Group plc – Portfolio company Oxford Nanopore Technologies announces £84.4m of additional funding
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore” or “the Company”) has announced that it has raised an additional £84.4 million of new capital from existing and new investors including International Holdings Company (IHC) and RPMI […]
Expansion of Axol Bioscience’s service offering for pre-clinical drug discovery New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform Cambridge, UK: Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease-relevant cell-based assay systems to the drug discovery industry, today announced […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
